Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

NCT00482508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Omalizumab

Sponsor

Novartis

Collaborators

[object Object]